- Home
- AXR vs CRVO Comparison
AXR vs CRVO Comparison
Compare AXR & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXR
- CRVO
- Stock Information
- Founded
- AXR 1961
- CRVO 2001
- Country
- AXR United States
- CRVO United States
- Employees
- AXR N/A
- CRVO N/A
- Industry
- AXR Homebuilding
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- AXR Real Estate
- CRVO Health Care
- Exchange
- AXR Nasdaq
- CRVO Nasdaq
- Market Cap
- AXR 110.0M
- CRVO 95.4M
- IPO Year
- AXR N/A
- CRVO N/A
- Fundamental
- Price
- AXR $24.55
- CRVO $9.80
- Analyst Decision
- AXR
- CRVO Strong Buy
- Analyst Count
- AXR 0
- CRVO 8
- Target Price
- AXR N/A
- CRVO $25.43
- AVG Volume (30 Days)
- AXR 18.3K
- CRVO 1.5M
- Earning Date
- AXR 03-07-2025
- CRVO 05-13-2025
- Dividend Yield
- AXR N/A
- CRVO N/A
- EPS Growth
- AXR 472.07
- CRVO N/A
- EPS
- AXR 2.41
- CRVO N/A
- Revenue
- AXR $58,052,000.00
- CRVO $9,737,974.00
- Revenue This Year
- AXR N/A
- CRVO N/A
- Revenue Next Year
- AXR N/A
- CRVO N/A
- P/E Ratio
- AXR $10.20
- CRVO N/A
- Revenue Growth
- AXR 30.35
- CRVO 36.29
- 52 Week Low
- AXR $15.88
- CRVO $1.80
- 52 Week High
- AXR $39.67
- CRVO $25.69
- Technical
- Relative Strength Index (RSI)
- AXR 68.79
- CRVO 55.40
- Support Level
- AXR $17.60
- CRVO $9.03
- Resistance Level
- AXR $19.81
- CRVO $10.89
- Average True Range (ATR)
- AXR 1.30
- CRVO 1.90
- MACD
- AXR 0.81
- CRVO -0.29
- Stochastic Oscillator
- AXR 97.75
- CRVO 32.37
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.